Form 4/A for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-06-02 16:32:34 ET · period of report 2026-05-26 · accession 0001106578-26-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AT | 2026-06-02 16:32 | 2026-05-26 | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale | $575.96 | -1,500 | 43.2K | -3% | -$863.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-26 | S | D | 1,500 | $575.96 | 43,153 | D | — | — | (F1) This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. (F2) The Form 4 being amended originally used transaction code P as a result of administrative error. This amendment is being filed to use the correct transaction code S. The transaction was at all times reported as a disposition of shares: the original Form 4 designated the shares as Disposed of "(D)" in Column 4, reported a corresponding reduction in the Amount of Securities Beneficially Owned Following the Reported Transaction (from 44,653 shares to 43,153 shares), and, as described in footnote 1, disclosed that the transaction was a sale of shares acquired on option exercise pursuant to the reporting person's Rule 10b5-1 trading plan. (F3) This transaction was executed in multiple trades at prices ranging from $575.51 to $576.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |